Washburn Therapeutics Inc. is developing biologically active gels that control inflammation by selectively neutralizing pro-inflammatory cytokines based on a technology being licensed exclusively by t ...SBIR Phase I 2013 Department of Defense Defense Health Program
DESCRIPTION (provided by applicant): Chronic wounds developed by patients with diabetes are becoming an increasing burden for Americans and our health care system. Diabetic foot ulcers cost tens of th ...SBIR Phase I 2010 Department of Health and Human Services
Washburn Therapeutics, Inc.
| 6743 Wilkins Ave.
Pittsburgh, PA, -
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||2|